Welcome to Pfizer’s News & Media Center—designed to give you immediate access to timely and relevant information about our company. In this section you will find information and resources for journalists including current and archived Pfizer press releases, a full company press kit, and a comprehensive collection of images and videos in our multimedia library.
Important New Mylotarg Information
Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg.
- Press release
- Acute Myeloid Leukemia (AML) Fact Sheet
- Prescribing Information
- Dear Healthcare Professional Letter
NEW YORK and CAMBRIDGE, Mass., Sept. 1 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) and FoldRx Pharmaceuticals, Inc.
ROCKLAND, Mass. and NEW YORK, Sept. 1 /PRNewswire-FirstCall/ -- EMD Serono, Inc. and Pfizer Inc.
NEW YORK, Aug. 23 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE :PFE) announced today that the SUN 1087 trial of sunitinib in combination with erlotinib versus erlotinib demonstrated a statistically significant improvement in Progression-Free but not in Overall Survival in patients with previously treated advanced non-small cell lung cancer (NSCLC).
NEW YORK, Aug.
NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) announced today that the U.S.
Recent Press Statements
Clinical Trials
April 21, 2010 — Pfizer Statement on Conducting Clinical Trial
Pfizer's Collaboration with Healthcare Professionals and Clinical Investigators
Additional Press Statements
Trovan / Nigeria Clinical Study
Intellectual Property and American Competitiveness
Teleconference: Prevenar 13
Pfizer signs long-term agreement to supply Prevenar 13 to world's poorest countries.
Investor Presentations
Access the Pfizer Presentation Archive to view Executive Leadership presentations to shareholders, analysts, and global health care conferences.
Executive Speeches & Commentary
View Executive Leadership speeches on a variety of topics.
Pfizer Pipeline Update – Our Medicines in Development
Visit the Pfizer Pipeline to learn more about exciting breakthroughs with our medicines in development. With the largest pipeline in the pharmaceutical industry, Pfizer and our partners are focusing on discovering and developing new medicines across 10 therapeutic areas.
Stay on top of Pfizer breaking news: Get News Alerts by RSS.
Follow us
Pfizer Twitter Community
Stock Quote Disclaimer
20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.
Stock Symbol: PFE Stock Exchange: NYSE
Stock Quote at: Sep 2 2010 4:00PM
| Last 16.40 | Change 0.12 |
| %Change | 0.74 | Vol. | 36,174,151 |
| Day High | 16.43 | 52 Wk. High | 20.36 |
| Day Low | 16.25 | 52 Wk. Low | 14.00 |
| Open | 16.33 | Mkt. Cap(Bil) | 131.83 |
| Prev. Close | 16.28 |
Our press kit provides information that might help you write stories or simply find out more about Pfizer.
Access Pfizer images and videos including product logos, headshots, and video clips.
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Privacy Policy
Copyright © 2002–2010 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
